Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
P/S ratio for Bellerophon Therapeutics (BLPH)
P/S ratio as of May 2024 (TTM): 0.1113
According to Bellerophon Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.111265. At the end of 2023 the company had a P/S ratio of 0.8624.
P/S ratio history for Bellerophon Therapeutics from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.8624 | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.60 | 4,032.73% | 🇺🇸 USA |
 Baxter BAX | 1.37 | 1,135.32% | 🇺🇸 USA |
 Lantheus Holdings LNTH | 3.56 | 3,102.62% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | 30.6 | 27,365.42% | 🇺🇸 USA |